MADHAVBAUG

VAIDYA SANE AYURVED LABORATORIES

Small Cap NSE: MADHAVBAUG
₹144.8
6.4 (4.62%)
As on 07 December, 2022 | 15:25

Vaidya Sane Ayurved Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in VAIDYA SANE AYURVED LABORATORIES

Start SIP

Vaidya Sane Ayurved Laboratories Share Price

Vaidya Sane Ayurved Laboratories Share Returns

  • Over 1 Month 8.51%
  • Over 3 Month 3.61%
  • Over 6 Month -19.82%
  • Over 1 Year

Vaidya Sane Ayurved Laboratories Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 152
Price to Book Ratio 4.2
EPS 3.3
Dividend 0.2
Relative Strength Index 48.43
Money Flow Index 59.78
MACD Signal 0.35
Average True Range 3.75

Vaidya Sane Ayurved Laboratories Investment Rating

  • Master Rating:
  • Vaidya Sane Ayurved Laboratories has an operating revenue of Rs. 264.71 Cr. on a trailing 12-month basis. An annual revenue growth of 44% is outstanding, Pre-tax margin of 6% is okay, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Vaidya Sane Ayurved Laboratories Financials
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Vaidya Sane Ayurved Laboratories Technicals

EMA & SMA

Current Price
144.8
6.4 (4.62%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 139.38
  • 50 Day
  • 140.66
  • 100 Day
  • 148.05
  • 200 Day
  • 20 Day
  • 139.65
  • 50 Day
  • 138.56
  • 100 Day
  • 146.59
  • 200 Day

Vaidya Sane Ayurved Laboratories Resistance and Support

PIVOT
₹138.4
Resistance
First Resistance 139.81
Second Resistance 141.2
Third Resistance 142.6
RSI 48.43
MFI 59.78
MACD Single Line 0.35
MACD -0.13
Support
First Resistance 137
Second Resistance 135.6
Third Resistance 134.2

Vaidya Sane Ayurved Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,200 320,000 100
Week 6,080 511,997 84.21
1 Month 8,471 696,452 82.22
6 Month 4,096 328,950 80.31

Vaidya Sane Ayurved Laboratories Result Highlights

Vaidya Sane Ayurved Laboratories Synopsis

NSE-Medical-Hospitals

Vaidya Sane Ayurved belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 74.71 Cr. and Equity Capital is Rs. 10.51 Cr. for the Year ended 31/03/2022. Vaidya Sane Ayurved Laboratories Ltd. is a Public Limited Listed company incorporated on 06/04/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U73100PN1999PLC013509 and registration number is 013509.
Market Cap 152
Sales 75
Shares in Float 0.36
No of funds
Yield 0.18
Book Value 4.06
U/D Vol ratio 1.3
LTDebt / Equity
Alpha 0.28
Beta 0.37

Vaidya Sane Ayurved Laboratories

Owner NameSep-22Mar-22Feb-22
Promoters 66.34%66.34%90.08%
Individual Investors 24.03%
Others 9.63%33.66%9.92%

Vaidya Sane Ayurved Laboratories Management

Name Designation
Dr. Rohit Madhav Sane Managing Director & CEO
Dr. Vidyut B Ghag Whole Time Director
Dr. Sushrut R Dambal Independent Director
Mr. Mahesh P Kshirsagar Independent Director
Mr. Ratnakar V Rai Independent Director

Vaidya Sane Ayurved Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vaidya Sane Ayurved Laboratories Corporate Action

Date Purpose Remarks
2022-11-10 Quarterly Results
Date Purpose Remarks
2022-11-18 INTERIM Declaration of Interim dividend at the rate of 0.25 per share {2.5%}.

Vaidya Sane Ayurved Laboratories FAQs

What is Share Price of Vaidya Sane Ayurved Laboratories ?

Vaidya Sane Ayurved Laboratories share price is ₹144 As on 07 December, 2022 | 15:11

What is the Market Cap of Vaidya Sane Ayurved Laboratories ?

The Market Cap of Vaidya Sane Ayurved Laboratories is ₹152.2 Cr As on 07 December, 2022 | 15:11

What is the P/E ratio of Vaidya Sane Ayurved Laboratories ?

The P/E ratio of Vaidya Sane Ayurved Laboratories is As on 07 December, 2022 | 15:11

What is the PB ratio of Vaidya Sane Ayurved Laboratories ?

The PB ratio of Vaidya Sane Ayurved Laboratories is 4.2 As on 07 December, 2022 | 15:11

Q2FY23